HB247 Alabama 2015 Session

Updated Feb 24, 2026

Summary

Primary Sponsor: Patricia Todd
Democrat
Session: Regular Session 2015
Title: HIV clinics, redispensing of prescription drugs not used by patients, pharmacies allowed
Summary: HB247 lets HIV-clinic pharmacies accept unused medications returned by patients and redistribute them under strict safety and record-keeping rules.
What This Bill Does
The bill defines HIV clinics and packaging terms like unit-dose and unit-of-issue. It allows HIV-clinic pharmacies to take back certain prescription drugs that were dispensed, if they were handled safely and remain properly labeled, and if a responsible nurse oversees security and administration. It requires written protocols for accepting, returning to stock, repackaging, labeling, and redistributing drugs, and it sets rules for how returned drugs can be reissued. It also lists drugs and packaging types that aren’t eligible for redispensing and addresses liability and FDA labeling requirements.

Who It Affects
HIV clinics and their contracted pharmacies, who can accept and redistribute unused medications under the rules
Patients at HIV clinics, who may receive medications that were returned and safely redistributed, subject to packaging and labeling requirements

Key Provisions
Defines terms: customized patient medication package, HIV clinic, repackaging, unit-dose package, and unit-of-issue package.
Allows clinics' pharmacies to accept returned prescription drugs if safety, control, labeling, and packaging conditions are met and a registered nurse or licensed practical nurse is responsible for handling the drugs.
Requires a written set of protocols for accepting, returning to stock, repackaging, labeling, and redispensing, with protocols kept on site and accessible to pharmacists.
Outlines redistribution rules: drugs returned in original unit-dose or unit-of-issue packaging can be returned to stock and redispensed; drugs repackaged into unit-dose must not be repackaged again and can be redispensed only in the same packaging and only once; no adding to partially used unit-of-issue packages.
Lists exclusions from the program: controlled substances, customized patient medication packages, non-unit-dose or improperly labeled drugs, and drugs not meeting FDA requirements or manufacturer registration.
Addresses liability: drug manufacturers are not liable in certain civil actions absent gross negligence for donated or dispensed drugs under this section.
Effective date: the act becomes law on the first day of the third month after passage.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.
Subjects: Health Care Facilities